Author:
Owen Richard R,Drummond Karen L,Viverito Kristen M,Marchant Kathy,Pope Sandra K,Smith Jeffrey L,Landes Reid D
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Informatics,Health Policy,General Medicine
Reference49 articles.
1. Yu W, Ravelo A, Wagner TH, Phibbs CS, Bhandari A, Chen S, Barnett PG: Prevalence and costs of chronic conditions in the VA health care system. Med Care Res Rev. 2003, 60 (3): 146S-147S. 10.1177/1077558703257000.
2. Blow FC, McCarthy JF, Valenstein M, Visnic S, Welsh D, Mach J: Care for Veterans with psychosis in the Veterans Health Administration. FY10: 12th annual National Psychosis Registry report. 2010, Ann Arbor, MI: Serious Mental Illness Treatment Research and Evaluation Center (SMITREC), Health Services Research and Development Center of Excellence
3. Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK: Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. Am J Psychiatry. 2006, 163 (4): 611-622. 10.1176/appi.ajp.163.4.611.
4. Lambert BL, Cunningham FE, Miller DR, Dalack GW, Hur K: Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in Veterans Health Administration patients with schizophrenia. Am J Epidemiol. 2006, 164 (7): 672-681. 10.1093/aje/kwj289.
5. Leslie DL, Rosenheck RA: Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry. 2004, 161 (9): 1709-1711. 10.1176/appi.ajp.161.9.1709.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献